Published in Hepatology on June 23, 1983
Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis (2006) 1.23
Lipids changes in liver cancer. J Zhejiang Univ Sci B (2007) 1.06
Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases. Lipids Health Dis (2008) 0.87
High-density lipoprotein response to alcohol consumption and abstinence as an indicator of liver function in alcoholic patients. Can Med Assoc J (1984) 0.84
Metabolism of high density lipoproteins in liver cancer. World J Gastroenterol (2007) 0.79
Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer (1980) 3.82
Group-specific antigen expression during embryogenesis of the genome of the C-type RNA tumor virus: implications for ontogenesis and oncogenesis. Proc Natl Acad Sci U S A (1970) 3.71
Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg (1965) 2.10
Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med (1980) 2.00
Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med (1971) 1.98
Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome. Am J Med (1971) 1.90
Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg). Gastroenterology (1978) 1.89
Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med (1971) 1.89
Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80
Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med (1966) 1.79
Fulminant B viral hepatitis: role of delta agent. Gastroenterology (1984) 1.74
Prevalence of the group-specific (gs) antigen and infectious virus expressions of the murine C-type RNA viruses during the life span of BALB-cCr mice. Int J Cancer (1972) 1.70
Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. Gastroenterology (1983) 1.70
Diagnostic features of tuberculous peritonitis in the absence and presence of chronic liver disease: a case control study. Am J Med (1996) 1.62
Lymphocyte stimulation in hepatitis B infections. N Engl J Med (1975) 1.60
Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer (1984) 1.57
Liver replacement for alpha1-antitrypsin deficiency. Surgery (1977) 1.53
Long term follow-up studies of patients surviving fluminant viral hepatitis. Gastroenterology (1974) 1.51
Twenty isoniazid-associated deaths in one state. Am Rev Respir Dis (1989) 1.50
Murine C-type RNA virus from spontaneous neoplasms: in vitro host range and oncogenic potential. Science (1973) 1.48
Naturally occurring sarcoma virus of the BALB/cCr mouse. J Natl Cancer Inst (1974) 1.38
Familial hepatoma with hepatitis-associated antigen. Ann Intern Med (1971) 1.34
Hepatocellular carcinoma and oral contraceptives. Br J Cancer (1983) 1.30
Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis (1999) 1.29
Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology (1999) 1.29
Hepatic necrosis associated with halothane anesthesia. Am J Med (1969) 1.27
Peliosis hepatis in a patient with human immunodeficiency virus infection. AJR Am J Roentgenol (1991) 1.23
Cirrhosis associated with partial deficiency of alpha-1 antitrypsin in an adult. Ann Intern Med (1973) 1.21
Viral hepatitis b in neonates and infants. Am J Med (1973) 1.20
A prospective, randomized controlled trial of chronic esophageal variceal sclerotherapy. Hepatology (1985) 1.19
5-Flourouracil in hepatocellular carcinoma: report of twenty-one cases. Cancer (1977) 1.13
Appraisal of the mortality in acute fulminant viral hepatitis. N Engl J Med (1968) 1.07
An ultrastructural study of liver explants from infants with vertically transmitted hepatitis. Exp Mol Pathol (1973) 1.07
Survival in patients with postnecrotic cirrhosis and Laennec's cirrhosis undergoing therapeutic portacaval shunt. Gastroenterology (1977) 1.06
Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses. J Virol (1976) 1.06
The changing incidence of association of hepatitis B with hepatocellular carcinoma in California. Am J Clin Pathol (1977) 1.05
Viral hepatitis: a pathologic spectrum. Am J Med Sci (1976) 1.04
The bile duct adenoma. A lesion distinct from Meyenburg complex. Arch Pathol Lab Med (1984) 1.03
Hepatitis-associated antigen: improved sensitivity in detection. Am J Clin Pathol (1971) 1.02
Neoplasm induction by murine type-C viruses passaged directly from spontaneous non-lymphoreticular tumours. Nat New Biol (1973) 1.02
Tetracycline-induced fatty liver in nonpregnant patients. A report of six cases. Am J Surg (1967) 1.01
Incidence of spontaneous neoplasms in breeding and retired breeder BALB-cCr mice throughout the natural life span. Int J Cancer (1972) 1.01
Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat. Hepatology (2000) 1.01
Post-jejunoileal-bypass hepatic disease. Its similarity to alcoholic hepatic disease. Am J Clin Pathol (1975) 1.01
Non-A, non-B hepatitis transmission in chimpanzees: a project of the transfusion-transmitted viruses study group. Intervirology (1978) 1.00
Incidence of spontaneous neoplasms in F344 rats throughout the natural life-span. J Natl Cancer Inst (1975) 0.98
Immunohistochemical localization of the delta antigen associated with hepatitis B virus in liver biopsy sections embedded in Araldite. Histopathology (1984) 0.98
Portal hypertension in a patient with osteopetrosis. A case report with discussion of the mechanism of portal hypertension. Arch Intern Med (1971) 0.97
Screening donors for xenotransplantation. The potential for xenozoonoses. Transplantation (1994) 0.97
An improved method for enumeration of X-C cell assay for murine leukemia virus. Appl Microbiol (1973) 0.96
Hepatitis, alcohol consumption, cigarette smoking, and hepatocellular carcinoma in Los Angeles. Cancer Res (1983) 0.96
Delta agent superinfection. Rapidly progressive liver disease in a hepatitis B virus carrier. Arch Pathol Lab Med (1985) 0.96
Sclerosing hepatic carcinoma: relationship to hypercalcemia. Liver (1981) 0.95
Cirrhotic hydrothorax. Further evidence that an acquired diaphragmatic defect is at fault. Arch Intern Med (1970) 0.95
The early stage of liver injury in the alcoholic. Medicine (Baltimore) (1967) 0.95
The nature and origin of proliferated bile ductules in alcoholic liver disease. Am J Clin Pathol (1983) 0.95
Pathologic features of the liver in acquired immune deficiency syndrome (AIDS). Liver (1986) 0.94
Immunoglobulin levels in detection of viral hepatitis. Am J Clin Pathol (1970) 0.94
Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens. Gastroenterology (1979) 0.93
Oncogenic potential of murine C-type RNA virus passaged directly from naturally occurring tumors of the BALB-cCr mouse. J Natl Cancer Inst (1973) 0.93
Acute submassive hepatic necrosis due to methyldopa. A case demonstrating possible initiation of chronic liver disease. Gastroenterology (1974) 0.91
Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus. J Immunol (1976) 0.90
Investigations of survival properties of airborne murine leukemia virus. J Natl Cancer Inst (1970) 0.90
Transfusion-transmitted viruses study: experimental evidence for two non-A, non-B, hepatitis agents. J Infect Dis (1980) 0.90
Enzyme-linked immunosorbent assay for detection of antibodies to murine hepatitis virus. J Clin Microbiol (1979) 0.89
Virus-like particles in livers of infants with vertically transmitted hepatitis. Arch Pathol (1972) 0.89
Assay in the mouse for delayed-type hypersensitivity to murine leukemia virus. J Natl Cancer Inst (1975) 0.89
Systemic-portal arteriovenous fistulas: pathological and hemodynamic observations in two patients. Surgery (1969) 0.89
Tubular dysfunction in the deeply jaundiced patient with hepatorenal syndrome. Hepatology (1985) 0.88
An immunoperoxidase technic for the demonstration of the hepatitis B surface antigen in human livers. Am J Clin Pathol (1976) 0.88
Idiopathic fatty liver of pregnancy: findings in ten cases. Medicine (Baltimore) (1984) 0.88
Ultrasonographic diagnosis of acute alcoholic hepatitis 'pseudoparallel channel sign' of intrahepatic artery dilatation. Gastroenterology (1993) 0.88
Membranous obstruction of the inferior vena cava in the United States. Medicine (Baltimore) (1985) 0.87
Glomerular tubular reflux--a morphologic renal lesion associated with the hepatorenal syndrome. Hepatology (1984) 0.87
Natural occurrence of tumors in mouse strains with different xenotropic and ecotropic endogenous viruses. J Natl Cancer Inst (1976) 0.87
Cirrhosis associated with partial deficiency of alpha-1-antitrypsin: a clinical and autopsy study. Hum Pathol (1975) 0.87
Spontaneous tumors and pathologic lesions in SWR-J mice. J Natl Cancer Inst (1973) 0.87
alpha-1-Antitrypsin phenotypes in hepatocellular carcinoma. Hepatology (1982) 0.86
Alcoholic foamy degeneration--a pattern of acute alcoholic injury of the liver. Gastroenterology (1983) 0.86
Puzzling jaundice. JAMA (1970) 0.86
An approach to C-type virus immunoprevention of spontaneously occurring tumors in laboratory mice. Cancer Res (1976) 0.85
Immunoprevention of x-ray-induced leukemias in the C57BL mouse. Proc Natl Acad Sci U S A (1977) 0.85
A distinctive perivenular hepatic lesion associated with heart failure. Am J Clin Pathol (1980) 0.84
Ultrastructural changes and virus-like particles localized in liver hepatocytes of chimpanzees infected with non-A, non-B hepatitis. J Med Virol (1981) 0.84
Giant mitochondria in the alcoholic liver diseases--their identification, frequency and pathologic significance. Liver (1984) 0.84
Tumors of the kidneys, synovia, exocrine pancreas and nasal cavity in BALB-cf-Cd mice. J Natl Cancer Inst (1973) 0.83
Serological detection of ectromelia virus antibody. Lab Anim Sci (1981) 0.83
Cordycepin inhibition of 3-methylcholanthrene-induced transformation in vitro. Proc Soc Exp Biol Med (1975) 0.83
Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology (1994) 0.83
Pancreatitis associated with alcoholic liver disease. A review of 1022 autopsy cases. Dig Dis Sci (1984) 0.82
Mammary tumors, hepatocellular carcinomas, and pancreatic islet changes in C3H-Avy Mice. J Natl Cancer Inst (1978) 0.81
Sex and strain differences in response to cocaine. Biochem Pharmacol (1984) 0.81
Identification of T lymphocytes and subsets in liver biopsy cores of acute viral hepatitis. Liver (1983) 0.81
Morphologic and immunohistochemical features of fulminant delta hepatitis. Hum Pathol (1985) 0.81
Chemical transformation of rat cells infected with xenotropic type-C RNA virus and its suppression by virus-specific antiserum. Proc Natl Acad Sci U S A (1977) 0.81
Enhancement of Friend leukemia virus infection in mice by Guaroa virus: quantitation and action of various oncogenic and nononcogenic viruses. Appl Microbiol (1970) 0.81
Development of a lymphocyte transformation microassay for murine leukemia virus. J Natl Cancer Inst (1976) 0.81
Nonimmunologic binding of horseradish peroxidase to hepatitis B surface antigen. A possible source of error in immunohistochemistry. Am J Clin Pathol (1980) 0.81